We uncover how genetic variation rewires RNA regulatory programs, neuronal metabolism, and circuit function to drive pediatric neurological disease.
From Patients to Precision Therapies
About the Lab
The Chen Lab investigates the genetic mechanisms underlying pediatric neurodevelopmental disorders. Building on advances in multi-level in vitro and in vivo 3D cellular systems, we aim to investigate how disease-causing variants alter gene networks, cellular states, and circuit-level phenotypes in the developing human brain.
The Chen Lab integrates human genetics, stem cell biology, genome engineering, and functional neuroscience to transform genetic discoveries into mechanistic insight and therapeutic innovation.
Research Focus
We combine human genetics, stem cell biology, and 3D brain models to understand how disease-causing variants reshape the developing brain — and how to fix them.
Millions of children worldwide are affected by neurodevelopmental disorders including autism spectrum disorder, epilepsy, and intellectual disability — yet the cellular and molecular mechanisms underlying most cases remain poorly understood. We take a genetics-first approach, starting from disease-causing variants identified in patients and asking how they alter gene expression, neuronal connectivity, and brain circuit function. Using patient-derived iPSC models and precision CRISPR genome editing, we aim to build mechanistic bridges between genetic variants and the cellular phenotypes that define disease.
The human brain cannot be studied directly — which is why we build it in a dish. Our lab develops and applies next-generation 3D cellular systems, including cerebral organoids, cortical assembloids, and cortico-motor assembloids, to recapitulate key aspects of human brain development. These models let us observe how neurons are born, migrate, wire together, and fire in real time — and critically, how disease variants derail each of these steps. We combine live imaging, electrophysiology, and single-cell genomics to extract rich phenotypic information at scale.
Alternative splicing is one of the most powerful mechanisms by which the genome generates cellular diversity — and one of the most frequently disrupted in neurological disease. We study how disease-causing variants in splicing regulators, including SRRM2 and related factors, remodel RNA processing networks during human neurodevelopment. By integrating RNA sequencing, single-cell multiomics, and functional perturbations in our 3D models, we aim to decode the splicing code of the developing brain and identify vulnerabilities that can be targeted therapeutically.
Understanding disease mechanisms is only the first step — our ultimate goal is to develop treatments. We use our mechanistic insights to design and test precision therapeutic strategies, with a particular focus on antisense oligonucleotides (ASOs). Our work on Timothy syndrome demonstrated that allele-specific ASOs can rescue neuronal phenotypes in human brain organoids and improve outcomes in mouse models — representing the first therapeutic strategy for this severe condition. We are now extending this approach to additional disorders and exploring AAV-based gene therapy and small molecule screens as complementary strategies.
Publications
Selected publications from the Chen Lab. For a complete list, see Google Scholar.
The Team
Lab Life
Science is better together — moments from the Chen Lab.
News & Updates
Latest updates from the Chen Lab.
Join Us
We are always looking for passionate scientists to join our team.
Contact
We welcome inquiries from prospective lab members, collaborators, and the press. Please reach out by email.